MissionIR Articles
-
MissionIRNewsBreaks – Clene Inc. (NASDAQ: CLNN) to Effect 1-for-20 Reverse Stock Split
Clene (NASDAQ: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nanomedicine Inc., a clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, today announced that it will effect a 1-for-20 reverse stock split at 12:01 a.m. ET on July 11, 2024. According to the…
-
MissionIRNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Enters Securities Purchase Agreements Worth Estimated $1.98M
CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, has entered into securities purchase agreements with health-care focused institutional investors. The agreements, which are for the purchase and sale of 1,425,000 shares of common stock, are comprised of…
-
MissionIRNewsBreaks – NextPlat Corp (NASDAQ: NXPL) Expands E-Commerce Program in China
NextPlat (NASDAQ: NXPL, NXPLW), a global e-commerce provider, today announced that it has expanded its e-commerce development program in China through a new agreement with a leading Chinese healthcare and nutritional products marketing and distribution services partner (the “marketing partner”). According to the update, the marketing partner will provide NextPlat with a full range of…
-
MissionIRNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Releases Q1 2024 Financial Reports, Business Update
Scinai Immunotherapeutics (NASDAQ: SCNI), a biopharmaceutical company focused on the development of inflammation and immunology (“I&I”) biological products and on providing contract development and manufacturing organization (“CDMO”) services through its Scinai Bioservices business unit, is reporting on its financial results for the quarter ended March 31, 2024; the company also released a business update. Notable financial numbers include…
-
MissionIRNewsBreaks – PaxMedica Inc. (PXMD) Intensifying Efforts to Achieve Significant Program Milestones
PaxMedica (OTC: PXMD), a biopharmaceutical company specializing in neurological disorders, is preparing to submit a New Drug Application (“NDA”) to the U.S. Food and Drug Administration (“FDA”) for using suramin to treat Human African Trypanosomiasis (“HAT”), a well-established treatment in East Africa for nearly a century. A recent article discussed PaxMedica gearing up for a…
-
MissionIRNewsBreaks – Correlate Energy Corp. (CIPI) Helping Companies ‘Beat the Grid for Costs’
Correlate (OTCQB: CIPI) is a tech-enabled development, finance and fulfillment platform for distributed energy solutions across North America. “Correlate Energy is a unique source for helping make renewable energy accessible to companies seeking to transition from more carbon-intensive fuels as part of a worldwide effort to forestall the harms of pollution-driven changes to the environment.…
-
MissionIRNewsBreaks – D-Wave Quantum Inc. (NYSE: QBTS) Hosts British Columbia Government Officials at Its Quantum Engineering Center of Excellence
D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software and services, and the world’s first commercial supplier of quantum computers, announced that Jagrup Brar, British Columbia (“B.C.”) Minister of State for Trade and Member of Legislative Assembly (“MLA”) for Surrey-Fleetwood, and Janet Routledge, B.C. Parliamentary Secretary for Labour and MLA for…
-
MissionIRNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Eyeing Favorable Strategic Partnering with Leading GLP-1 Players
Lexaria Bioscience Corp. (NASDAQ: LEXX), a global innovator in drug delivery platforms, is doubling down on glucagon-like peptide 1 (“GLP-1”) studies for the 2024 calendar year. “The company is optimistic that the studies will yield positive results, not just in the potential treatment of diabetes but also in weight management, which has been directly linked…
-
MissionIRNewsBreaks – Annovis Bio Inc. (NYSE: ANVS) Announces Filing of Provisional Patent Covering Manufacturing Process of New Solid Forms of Buntanetap
Annovis Bio (NYSE: ANVS), a late-stage, drug-platform company developing novel therapies for neurodegenerative diseases such as Alzheimer’s (“AD”) and Parkinson’s disease (“PD”), is announcing the filing of a provisional patent. This patent covers the manufacturing process of new solid forms of buntanetap (formerly known as Posiphen or ANVS401), which targets neurodegeneration by inhibiting the formation of…
-
MissionIRNewsBreaks – Mullen Automotive Inc.’s (NASDAQ: MULN) Subsidiary Secures EPA Certification for Class 4 EV Commercial Trucks
Mullen Automotive (NASDAQ: MULN), an electric vehicle (“EV”) manufacturer, an electric vehicle (“EV”) manufacturer, today announced that its subsidiary, Bollinger Motors, has received its Certificate of Conformity from the Environmental Protection Agency (“EPA”) for its Class 4 B4 Chassis Cab. The certificate is another important milestone for Bollinger Motors as it moves closer to delivering…
-
MissionIRNewsBreaks – D-Wave Quantum Inc. (NYSE: QBTS) Featured in The Stock2Me Podcast
D-Wave (NYSE: QBTS) is a leader in quantum computing systems, software and services focused on delivering customer value via practical quantum applications for problems within logistics, artificial intelligence, materials sciences, drug discovery, scheduling, fault detection and financial modeling. The company was featured in the latest episode of The Stock2Me Podcast. Murray Thom, vice president of quantum technology…
-
MissionIRNewsBreaks – SuperCom Ltd. (NASDAQ: SPCB) Announces More than $3M in Orders from European Governments
SuperCom Ltd. (NASDAQ: SPCB), a global provider of secure solutions for the e-Government, IoT, and cybersecurity sectors, is announcing the receipt of orders from European governments. The orders, valued at over $3 million, are expected to be delivered by the end of Q3 2024. “We are pleased to continue our collaboration with European governments through…
-
MissionIRNewsBreaks – D-Wave Quantum Inc. (NYSE: QBTS) Unveils New Hybrid Quantum Solver Designed to Simplify and Accelerate Successful Quantum Technology Adoption
D-Wave Quantum (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software and services, and the world’s first commercial supplier of quantum computers, has unveiled a new hybrid quantum solver for addressing nonlinear problems. The new solver, which is capable of handling production-scale use casesup to two million variables with no linearization required, was launched…
-
MissionIRNewsBreaks – Reunion Gold (TSX.V: RGD) (OTCQX: RGDFF) Issues Reminder for Warrant Holders Regarding Expiration Date
Reunion Gold (TSX.V: RGD) (OTCQX: RGDFF), a leading gold explorer in the Guiana Shield, has released a reminder for holders of outstanding common share purchase warrants issued on July 8, 2022; the company is reminding holders that the warrants are set to expire at 4 p.m. Vancouver time on July 8, 2024. According to the reminder, 41,338,257 warrants…
-
MissionIRNewsBreaks – Annovis Bio Inc. (NYSE: ANVS) Officials to Present Results from Alzheimer’s Study at AAIC 2024
Annovis Bio (NYSE: ANVS), a late-stage, drug-platform company developing novel therapies for neurodegenerative diseases such as Alzheimer’s (“AD”) and Parkinson’s disease (“PD”), will be presenting results from its latest Alzheimer’s study at the Alzheimer’s Association International Conference(R) 2024 (“AAIC”). The conference is slated to run from July 28–Aug. 1, 2024, in Philadelphia as well as online.…
-
MissionIRNewsBreaks – Freight Technologies Inc. (NASDAQ: FRGT) Management Presents During Chardan Transport Platform Tech Series
Freight Technologies (NASDAQ: FRGT), a technology company whose custom-developed Fr8App, an industry-leading freight-matching platform powered by artificial intelligence (“AI”) and machine learning, offers a real-time portal for business-to-business (“B2B”) cross-border shipping and domestic shipping, participated in Chardan’s recent Transport Platform Tech Series event. The event brought together key industry players and highlighted the company’s focus…
-
MissionIRNewsBreaks – Reunion Gold (TSX.V: RGD) (OTCQX: RGDFF) Announces Annual Shareholder Meeting, Outlines Agenda Items for Voting
Reunion Gold (TSX.V: RGD) (OTCQX: RGDFF), a leading gold explorer in the Guiana Shield, has scheduled an annual general and special shareholders meeting. The meeting will be held July 9, 2024, with agenda items that include voting and approving an arrangement with G Mining Ventures. According to the announcement, shareholders will vote to approve a statutory…
-
MissionIRNewsBreaks – McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) Chairman & Chief Owner Featured in Latest Episode of The MiningNewsWire Podcast
McEwen Mining (NYSE: MUX) (TSX: MUX) is an asset rich diversified gold and silver producer in the Americas with a large exposure to copper through its McEwen Copper subsidiary. The company’s Chairman and Chief Owner, Rob McEwen, was featured in the latest episode of The MiningNewsWire Podcast as part of IBN’s sustained effort to provide…
-
MissionIRNewsBreaks – PaxMedica Inc. (NASDAQ: PXMD) Marks Major Milestone in Preparations for NDA Submission, Global Suramin Supply
PaxMedica (NASDAQ: PXMD), a biopharmaceutical company focused on advancing treatments for neurological disorders, recently completed its three registration/validation batches of PAX-101, an IV formulation of suramin. “This accomplishment marks a significant step toward submitting a New Drug Application (‘NDA’) to the U.S. Food and Drug Administration (‘FDA’) in the fourth quarter of 2024. This step…
-
MissionIRNewsBreaks – Annovis Bio Inc. (NYSE: ANVS) Announces Results of Recent Alzheimer’s Study, Schedules Investor Call
Annovis Bio (NYSE: ANVS), a late-stage, clinical-drug-platform company developing novel therapies for neurodegenerative disorders such as Alzheimer’s disease (“AD”) and Parkinson’s disease (“PD”), is reporting the results of its recent phase 2/3 Alzheimer’s study. The study was designed to evaluate Buntanetap, the company’s lead drug candidate. According to the report, key findings indicate that Buntanetap showed…
Search Articles
Latest Articles
- MissionIRNewsBreaks – Beeline Holdings, Inc. (NASDAQ: BLNE) Closes $7.4M Registered Direct as Company Targets Cash Flow Positive in Q1 2026
- MissionIRNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Reports Q3 Results and Advances Lead Candidate TPI 287 Toward Phase 2 GBM Study
- MissionIRNewsBreaks – SuperCom Ltd. (NASDAQ: SPCB) Secures First Missouri Contract as PureSecurity Platform Displaces Incumbent Provider
- Safe & Green Holdings Corp. (NASDAQ: SGBX) Sets December 29 Annual Meeting as It Advances Energy Strategy and Finalizes Olenox–Safe & Green Merger
- MissionIRNewsBreaks – Safe Pro Group Inc. (NASDAQ: SPAI) Highlights Operational Progress Following $20 Million in Strategic Investments